Mortgage Blog Vaccine developer Vaxcyte stock soars on results of experimental pneumonia jab firststargroup October 25, 2022 The study results could put the vaccine in line to challenge those from Pfizer and Merck.
The study results could put the vaccine in line to challenge those from Pfizer and Merck.
